Innovation in
Health Tech

Left Ventricular Ejection Fraction in Patients Undergoing Transcatheter Aortic Valve Implantation Insights From the COMPARE-TAVI-1 Study 

Paradoxical Normal‐Flow Aortic Stenosis Despite Reduced Left Ventricular Ejection Fraction: Insights From the Randomized COMPARE‐TAVI 1 Trial

One-year outcomes of novel balloon-expandable versus contemporary transcatheter heart valves in severe aortic stenosis: the LANDMARK trial

Quantitative video densitometric assessment of aortic regurgitation in MyVal, Sapien, and Evolut THV series: Results from the LANDMARK trial

Impact of Flow-status on Effective Orifice Area in 3 Transcatheter Heart Valves: a COMPARE-TAVI 1 Sub study

Cardiac damage and outcome in transcatheter aortic valve replacement patients – a COMPARE-TAVI 1 trial sub-study 

A comparison of transcatheter aortic valve prosthesis platforms: Myval, Sapien, and Evolut in severe symptomatic aortic stenosis and low moderate risk patients 

Balloon‐Expandable MyVal Octacor Versus Self-Expanding Evolut PRO/PRO+ and Accurate Neo2: Short‐Term Outcomes From Propensity‐Matched Analysis

Comparative 30-day Echocardiographic Outcomes of MyVal versus Sapien and Evolut THVs: Insights from LANDMARK Trial

Head-to-Head Comparison of Meril Myval Series Balloon-Expandable and Abbott Portico Series Self-Expanding Transcatheter Aortic Valves—A Single-Center Experience 

Comparison of Self-Expandable Accurate Neo-2 and Balloon-Expandable MyVal Transcatheter Heart Valves at 4-Year Follow-Up 

Early Conduction Abnormalities Following Trans Catheter Aortic Valve Implantation In Al Najaf Cardiac Center: Single-Center Experience From Iraq 

"Four-year durability of the MyVal balloon-expandable transcatheter aortic valve"
 

Single‐Center Evaluation of the Myval Balloon‐Expandable Transcatheter Heart Valve: A Follow‐Up Study: A Retrospective Cohort Study

Single-Centre Experience with the Balloon-Expandable Myval Transcatheter Aortic Valve System with the First 200 Patients: 30-Day and 1-Year Follow-Up

A new and easy parameter to predict the requirement for permanent pacemaker implantation after transaortic valve
implantation: aortic knob calcification 

Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals
with severe aortic stenosis 

Immediate and Early Outcomes Following Myval Octacor Transcatheter Heart Valve Implantation for the Treatment of Patients With Severe Aortic Valve Stenosis: The OCTACOR‐EU Study

"Percutaneous Pulmonary Valve Implantation In Native
Right Ventricular Outflow Tract Using Myval™ Without
Pre‐Stenting"

SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial

The Myval Balloon-Expandable Transcatheter Heart Valve Implant in Aortic and Mitral Interventions: A Single-Center Experience

Learning Curve for Starting a Successful Single-Centre TAVR Programme with Multiple Devices: Early and Mid-Term Follow-Up

Early clinical and haemodynamic matched comparison of balloon-expandable valves (MATCH-BALL)

Operator preference and determinants of size selection
when additional intermediate-size aortic transcatheter heart valves are made available (MATCH-BALL Protocol)

Comparative Outcomes of Myval Balloon Expandable Valve Versus Evolut R/Pro Self Expanding Valves inSevere Aortic Stenosis: A Systematic Review and Meta-Analysis

Short- and Midterm Outcomes Following TAVR With Two Intra-Annular Transcatheter Aortic Valves

Early Outcomes With Three TAVI Valves (Myval, Sapien, and Evolut Series) in Women - Substudy of Landmark Trial 

“Smart” Analysis of the Landmark Trial - Early Outcomes
With Latest Generation Tavi Valves in Patients With a Small
Aortic Annulus 

The Current Generation of THV: A Single-Center Propensity Score Match Analysis

Initial Experience With the Myval Balloon-Expandable Transcatheter Heart Valve in Argentina

Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut)
Implantation: Insights From the

Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Comparison of the Self-Expandable Acurate Neo 2 and the New Balloon-Expandable Myval Series Transcatheter Heart Valve at 4-Year Follow-Up

Win Ratio Analysis of the LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

 The First Pediatric LAMPOON Procedure for TMVR (Valve-in-Ring)

Percutaneous Mitral Valve-in-Ring Procedure in a Case of Severe Mitral Regurgitation Repaired with a Surgical Flexible Ring: A Step-by-Step Description

Percutaneous pulmonary valve implantation with a Myval Octacor device in an adolescent patient: First Polish experience

Transcatheter valve-in-valve replacement for degenerated mitral bioprosthesis using Myval device

Unanticipated change in access site and anesthetic considerations for transcarotid transcatheter aortic valve implantation procedure: A case report

Six-Year Follow-Up of TAVI In Rheumatic Severe Aortic Stenosis Using MYVAL THV: A Case Report  

Redo-Transcatheter Aortic Valve Replacement for Migration of Myval Transcatheter Heart Valve in Pure Aortic Regurgitation

When surgery is not an option: case report of transcatheter valve-in-valve replacement for mitral valve dysfunction

Transcatheter tricuspid valve-in-valve implantation in a paediatric patient: a case report

A challenging TAVI-in-TAVI with Balloon expandable
Myval and Chimney Stenting of LMCA 

Transcatheter Aortic Valve Replacement in Pure Native
Valve Aortic Regurgitation Using a 35‐mm Balloon
Expandable Myval XXL

Reflections on transfemoral TAVI in dextrocardia with severe aortic regurgitation: Navigating anatomical complexity, off-label innovation, and future directions

First Transcatheter Valve-in-Valve Implantation With Myval Octacor Into a Failed Biological Prosthetic Aortic Valve in Serbia

Successful Management of Myval Transcatheter Heart Valve Embolization into Abdominal Aortic Aneurysm During Transcatheter Aortic Valve Replacement

Single-stage transcatheter mitral valve in valve implantation and paravalvular leak closure following failure of bioprosthetic valve and cardiogenic shock

Transcatheter Mitral Valve-in-valve Implantation with
the Balloon-expandable Myval Device 

Transcatheter aortic valve implantation using balloon-expandable Myval transcatheter heart valve in a patient with bicuspid aortic valve with low-flow , low-gradient
severe aortic stenosis

Transcarotid aortic valve implantation using the novel
Myval Octacor valve: First experience in Poland 

Coronary Artery Protection with Chimney Stent in High-Risk Case of Coronary Occlusion in Transcatheter Aortic Valve Implantation

Transcatheter pulmonary valve implantation with custom-made 35-mm Myval™ transcatheter heart valve 

Coronary alignment by OctaAlign technique using
Myval Octacor transcatheter heart valve in a bicuspid aortic valve 

Direct aortic TAVI via anterior right mini thoracotomy using 32 mm myval for pure aortic regurgitation

Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic
valve with 1 year follow-up

Transcatheter Valve-In-Valve Implantation in Patients With Fluoroscopically Invisible Tricuspid Valve Prostheses

Prosthetic Heart Valve Interactions and Their Clinical Significance During Transcatheter Left-Sided Double Valve Replacement

Prediction of Prosthetic Heart Valve Interaction During Transcatheter Double-Valve Replacement Using a Bench Model

Transcatheter aortic valve replacement in patients with a pre-existing prosthetic mitral valve: a single center
experience with two cases

The new balloon-expandable MyVal transcatheter heart valve: only good news?

Myval transcatheter heart valve system: a new TAVI contender and remaining uncertainties

Win ratio analysis of the LANDMARK trial

Glimpse Into the Hemodynamic Performance of Myval Series vs Sapien
3 Ultra Resilia

Transcatheter Aortic Valve in Failing Mechanical Aortic Valve

Early Outcomes of Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis With Myval Versus Edwards Sapien 3 Valve: A Systematic Review and Meta-Analysis

Effectiveness and Safety of Myval Versus Other Transcatheter Valves in Patients Undergoing TAVI: A Meta‐Analysis

A systematic review and meta-analysis of the hemodynamics and outcomes of the Myval balloon-expandable valve in patients with severe aortic stenosis and with aortic regurgitation

Myval transcatheter aortic valve series: An innovation in transcatheter aortic valve implantation technology

Transcatheter Heart Valves—An Update on Types of Valves Available, Hardware Characteristics, and Patient Selection: An Indian Perspective

Pediatric cardiac interventions: Innovations from India

Myval Transcatheter Heart Valve: The Future of Transcatheter Valve
Replacement and Significance in Current Timeline

LANDMARK trial: Update in statistical analytical plan and protocol for the one-year report

Head-to-head comparison of balloon-expandable transcatheter heart
valves

Four-year follow-up after prophylactic awake peripheral veno-arterial ECMO  during transcatheter aortic valve replacement 

Clinical and angiographic outcomes of ultrathin Biomime versus thicker ultimate stents during primary percutaneous coronary interventions

Safety and Efficacy of BioMime Sirolimus-eluting Stent System in
All-comers: Real-world Population with Coronary Artery Stenosis: MILES
Global Registry 

Real-world evidence of BioMime sirolimus-eluting stent in obstructive
coronary artery disease: meriT -2 trial

Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in
Real- World Population at Single-Center: A Retrospective Observational Study

A Randomized Controlled Trial Comparing BioMime SirolimusEluting Stent with Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial

Clinical follow-up of long non-tapered sirolimus-eluting coronary stent in
real- world patients with de novo lesions: The Billar registry

Clinical outcomes of biodegradable polymer sirolimus-eluting stent in
coronary artery lesions patients: a retrospective analysis

Single long stents versus overlapping multiple stents in the
management of very long coronary lesions: comparisons of procedures
and clinical outcomes

Randomized comparison of biodegradable polymer ultra-thin
Sirolimus-eluting stent versus a durable polymer everolimus-eluting
coronary stent in patients with de novo native coronary artery lesions:
the meriT-V trial 

One-year outcomes of a BioMime sirolimus-eluting coronary stent system
with a biodegradable polymer in allcomers coronary artery disease
patients: The meriT-3 study

Late angiographic and clinical outcomes of the novel BioMime
sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform
and biodegradable polymer for the treatment of diseased coronary
vessels: results from the prospective, multi-centre meriT-2 clinical trial

First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vesselsresults from the meriT-1 trial

Long-term follow-up after ultrathin vs. conventional 2ndgeneration drugeluting stents: a systematic review and meta-analysis of randomized controlled trials

Newer generation ultra-thin strut drug- eluting stents versus older
second- generation thicker strut drug-eluting stents for coronary artery
disease: a meta-analysis of randomized trials

Strut coverage of the ultrathin BioMime stent: a single-centre
experience from the MILES-UK registry

Primary efficacy and safety outcomesof a sirolimus-eluting thin-strut
coronary stent system in all-comer patients undergoing PCI: the MILESUK registry

Safety and efficacy of sirolimuseluting stent system in all-comers realworld population with coronary artery stenosis: the MILES-GLOBAL study

Safety and performance of the biodegradable polymer-coated ultrathin
strut sirolimus-eluting coronary stent system for very long lesions: 12-month experience in real-world clinical practice 

Clinical outcomes from real-world patients treated with
biodegradable polymer coatedultrathin-strut sirolimus-eluting
coronary stent system- BioMimeGBPR

One-year clinical outcomes in patients implanted with biodegradable
polymer coated ultra-thin strut sirolimus-eluting coronary stent
system for the treatment of very long (≥40mm) lesions

Safety and efficacy of sirolimus-eluting stent system in all-comers real-world population with coronary artery stenosis: the MILES-GLOBAL study

Twelve-months clinical outcomes comparing biodegradable polymer
sirolimus-eluting stent versus durable polymer everolimus-eluting coronary stents in patients with de novo native
coronary artery lesions: the meriT-V randomized trial

Single long stent vs. overlapping multiple stents in the management of
very long coronary lesions: comparison of success rates and oneyear clinical outcomes

Efficacy and safety of an ultrathin strut sirolimus eluting stent with
biodegradable polymer in all-comers patients undergoing coronary
intervention 

Three-year clinical outcomes of BioMime sirolimus-eluting coronary
stent system with a biodegradable polymer in coronary artery disease
patients: a long-term follow-up of the meriT-2 study

How to make a deal with distal left main coronary artery type A trifurcation lesion

Efficacy of the novel BioMime sirolimus-eluting stents with a
biodegradable polymer in the treatment of de novo coronary
lesions: an angiographic sub-analysis of the combined meriT-1 and
meriT-2 prospective clinical trials

First-in-human evaluation of a novel sirolimus-eluting stent with a
bioabsorbable polymer for the treatment of single, de novo, noncomplex coronary lesions

Impact of the new BioMime sirolimus-eluting stent in complex patients of daily practice-preliminary results of the meriT-2 study

Moving towards biomimicrydevelopment of novel BioMime sirolimus eluting coronary stent system

Ultrathin struts drug-eluting stents: a state-of-the-art review

Novel bioabsorbable polymer and polymer-free metallic drugeluting stents

Innovative DES technologies from Meril

Advantages of novel BioMime sirolimus eluting coronary stent system. Moving towards biomimicry

Moving towards Biomimicry-the development of the novel BioMime sirolimus-eluting coronary stent system 

Cuspal dissection of aorta during percutaneous coronary intervention
to left anterior descending artery managed successfully

Bifurcation stenting. It’s easy. That’s what I thought

Inter-coronary communication in chronic total occlusion: in search of recognition 

Chronic total occlusion intervention with no-flow tackled successfully

Ostial circumflex stenting through left main-LAD stent: a challenge of
access in tortuous complex circumflex anatomy

In-situ intra procedure left main coronary artery thrombosis

A percutaneous coronary intervention complication: coronary perforation

IVUS guided stenting in moderate looking proximal coronary lesion

Comparison of over expansionvcapabilities and thrombogenicity at the
side branch ostia after implantation of our different drug eluting stents

BioMime a sirolimus-eluting coronary stent system for the treatment of
patients with de novo coronary lesions- ando-1 report

Very long stent technology: clinical and practical value

Preliminary Assessment of a Dedicated Bifurcation Stent Using  a Modified Technique in True Coronary Bifurcation Lesions: A Dual Centre Registry

Coronary Bifurcation Lesion Treatment with the BioMime™ Branch Sirolimus-Eluting Coronary Side-Branch Stent System: A Single-Center Experience

BioMime™ Branch-1: a randomized comparison of sirolimus-eluting coronary side branch stent systems and everolimus-eluting stent systems to assess safety and performance in Patients with de novo coronary bifurcation lesions

Long-Term Safety and Performance of BioMime Morph Sirolimus-Eluting
Coronary Stent System for Very Long Coronary Lesions in Real-world
Settings: Morph India study

Clinical outcomes of the BioMime™ Morph Coronary stent systme for long (30 to ≤ 56 mm length) coronary lesions: Three years follow-up of the Morpheus Global Registry.

Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions

Real-world experience with a 60 mm long stent in the setting of primary percutaneous coronary intervention

Percutaneous Intervention in Diffuse Coronary Disease: Overlapping Versus Single Very Long Stent Technique. Results From the OVERLONG Registry

One-year outcomes of novel BioMime™ Morph tapered stent in long and multiple coronary artery lesions

Feasibility and outcomes of left main to branch vessel PCI with novel tapered coronary stent in a tertiary care center: a real-world experience

Real-world experience with a tapered biodegradable polymer-coated sirolimus-eluting stent in Patients with long coronary artery stenosis

Clinical experience with 12-month follow-up in Patients after implantation of a novel long tapered sirolimus drug-eluting stent

Feasibility of implanting 50-60 mm-tapered drug eluting stents in chronic total occlusions

Comparison of clinical outcomes between very long stents and overlapping stents for the treatment of diffuse coronary disease in real clinical practice

Clinical outcomes of novel long-tapered sirolimus-eluting coronary stent system in real-world Patients with long diffused de novo coronary lesions

First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusion with the hybrid algorithm

First experience with the use of extra-long (40 to 60 mm) sirolimus-eluting stents in Patients with diffuse long
coronary lesions

Longitudinal stent deformation detected on coronary CT in the novel BioMime™ 60mm long sirolimus-eluting tapered stent

Clinical outcome of the world’s first tapered sirolimus eluting coronary stent system for long coronary lesions: a real-world experience

First Experience with very long coronary drug eluting stent

Initial experience with the novel BioMime™ Morph 40-60 mm long sirolimus-eluting tapered stent in long coronary lesions

Multicenter clinical outcomes of hybrid tapered sirolimus eluting coronary stent system with biodegradable polymer in long diffuse de novo coronary artery lesions

Real World Experience of the BioMime™ Morph tapered stent in a Tertiary Care Hospital

Experience of the management of complex long lesion by Indigenous BioMime™ Morph tapering stents

Long term outcome after revascularization of long coronary artery lesions with very long or overlapping stents. Insights from the propensity score matched registry

Use of BioMime™ Morph stent in treating left main triple vessel disease: a case report

Successful treatment of tandem calcific right coronary artery stenoses with 50 mm tapered BioMime™ Morph stent guided by intravascular ultra sound and rotablation using a sheath less guide via the radial access

Acute stent loss and its retrieval of a long, tapering Morph stent in a tortuous, calcified lesion

Tapered stents in long diffusely diseased coronary arteries-our experience

The perfect storm

Management of long complex CTO in LCX by indigenous BioMime™ Morph tapering stents from Meril

Intravascular ultrasonography guided 60-mm long drug eluting tapered stent implantation in a long-calcified lesion in a patient with stable coronary artery disease

First in Poland, unique 60-mm long single drug eluting tapered stent implantation in a patient with unstable angina

A report of successful procedural, clinical, and angiographic outcomes with a tapered stent of a patient in naturally tapered coronary vessel

Initial Experience with the novel BioMime 60mm-long sirolimus-eluting tapered stent system in long coronary lesions

Innovative DES technologies from Meril

Gone long, not wrong: BioMime Morph and a tale of coronary ambition

Treatment of long coronary lesions with single stent: BioMime Morph sirolimus-eluting tapered coronary stent system

Endovascular reconstruction of popliteal and infrapopliteal arteries for limb salvage and wound healing in Patients with critical limb ischemia-A retrospective analysis

Multiple coronary microfistulas between left anterior descending artery and left ventricle following myocardial infarction

Stent Crumpling as a Complication of Percutaneous Coronary Intervention, a Case Report and Literature Review

The ultrathin-strut everolimus-eluting stent in a real-world population: the Everythin multicenter registry

Safety and efficacy of Evermine50 Everolimus-eluting coronary stent system in patients with native coronary artery lesions: Three-year outcomes from a single-center

Clinical safety and performance of the world’s thinnest strut Evermine50™ Everolimus-eluting stent: A 24-month follow-up of Evermine50 EES-1 study

Procedural safety and outcome of ultrathin strut stents (<60 μm) in the management of very long coronary artery stenosis (>30 mm)-A retrospective real-world study

Clinical outcomes of ultrathin strut biodegradable polymer coated everolimus eluting stent in Patients with coronary artery disease

Clinical safety and efficacy of world’s thinnest (50μm), very long (>40 mm) everolimus eluting stent among real world Patients

Clinical outcomes of world’s thinnest (50μm) strut biodegradable polymer coated everolimus eluting coronary stent system in real-world Patients

Less is more: a new “thin-king” for DES?

Biodegradable polymer Evermine50™ everolimus eluting coronary stent system with ultrathin (50μm) strut

Device embolization during trans-radial percutaneous coronary intervention: Various approaches.A case series

One-year clinical outcomes of ultrathin strut everolimus eluting coronary system (50µm) for treatment of patient with de novo coronary artery lesions

1-year clinical outcomes after percutaneous coronary intervention with biodegradable polymer ultra-thin strut everolimus-eluting coronary stent system

Initial experience with ultrathin strut biodegradable polymer-coated everolimus-eluting coronary stent in coronary artery disease Patients

Clinical outcomes of ultrathin strut biodegradable polymer coated everolimus-eluting coronary stent system in treatment of patient with de novo coronary artery lesions

Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries

A real-world experience with a thin-strut Bioresorbable vascular scaffold system: a single-centre study

Imaging and two-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold:
the MeRes-1 extend trial

Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial

Pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system for treatment of de novo native coronary lesions: a sub-study of MeRes-1 trial

First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the
treatment of de novo native coronary artery lesions: MeRes-1 trial

The MeRes-1 Extend trial: 2-year clinical and 6-month imaging outcomes of thin-strut sirolimus-eluting BRS in Patients with de novo coronary artery lesions

Clinical and imaging outcomes of thin-strut sirolimus eluting BRS in Patients with de novo coronary artery lesions: the MeRes-1 extend trial

Implantation of thin-strut sirolimus-eluting bioresorbable vascular scaffold in Patients with de novo coronary artery lesions: 2-year clinical and 6-month imaging outcomes of the MeRes-1 extend trial

Real world follow-up one year of the novel MeRes100

Two-year clinical and imaging outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffolds in de novo coronary artery lesions: the MeRes-1 trial

Real world performance of the novel MeRes100™

Favorable outcomes for systemic pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system in treating de novo native coronary artery lesion: A sub study of MeRes-1 Trial

First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial

Quantitative angiographic analysis in Patients with de novo native coronary artery lesions treated with novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial

Fully bioresorbable vascular scaffolds: Lessons learned and future directions

Bioresorbable coronary scaffolds: deployment tips and tricks and the future of the technology

Bioresorbable scaffold The emerging reality and future directions

MeRes100™ -A sirolimus eluting bioresorbable vascular
scaffold system

Can the vanishing stent reappear? Fix the technique, or fix the device?

A fresh look at bioresorbable scaffold technology: Intuition pumps

Safety and Performance of the MOZEC Sirolimus-Eluting
Coronary Balloon in the Treatment of Stenotic Coronary Artery Lesions: A Real-world, Multicenter, Post-marketing

Clinical outcomes of a non-compliant balloon dilatation catheter: Mozec™ NC study

Complex coronary interventions with the novel Mozec™ CTO balloon: The Mozart registry

How to make a deal with distal left main coronary artery type a trifurcation lesion

Drug-coated balloons: technologies and clinical applications

Persistent stent thrombosis in a patient with non-ST segment elevation myocardial infarction and mild COVID-19

Twelve-month clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent in real-world Patients: a single-center experience

Safety and performance of sirolimus-eluting coronary stent system with biodegradable polymer: a retrospective analysis in real-world patient population

One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with coronary artery disease

Safety and clinical performance of biodegradable polymer coated sirolimus-eluting coronary stent in real-world Patients

One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with coronary artery disease

Evaluation of safety and efficacy of NexGen-an ultrathin strut and hybrid cell design cobalt-chromium bare metal stent implanted in a real-life patient population-the Polish NexGen™ Registry

Clinical safety and performance of novel ultra-thin strut cobalt chromium bare metal stent implanted in real-world Patients with coronary artery disease

Outcomes of aortic and mitral valve replacement with Dafodil TM pericardial Bioprosthesis over 5-years: DafodilTM-1 trial

Three-year Outcomes of Surgical Valve Replacement with Dafodil™ Pericardial Bioprosthesis: Dafodil™-1 Trial

Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial

12-month clinical outcomes of sirolimus-eluting bioresorbable peripheral scaffold system following percutaneous transluminal angioplasty of below-the-knee arteries in Patients with critical limb ischaemia: the CREDENCE™ BtK-1 study

Comparison of a Novel Liquid Embolic System with Commonly Used Embolic Agents in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas: A Single-Center Experience

Intermixed dimethyl-sulfoxide based non adhesive liquid embolic agents delivered serially via the same micro catheter for cerebral AVM treatment

OPTEM-OHCM Optimal Targeted Polymer-based Embolization for Obstructive Hypertrophic Cardio Myopathy 

Embolization Using the Novel Menox Liquid Embolic System for Arteriovenous Fistulas: A Case Report

Endovascular treatment of a post-traumatic pseudoaneurysm arising from a ruptured posterior tibial artery with Menox™ A case report

Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox™ in the endovascular treatment of cerebral arteriovenous malformations

Extending endovascular embolization to type A spinal peri-medullary arteriovenous fistula using liquid embolic agent: technical nuances, challenges and initial outcomes

Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas

Comparing Obtura Vascular Closure Device to Manual Compression for Achieving Hemostasis After Percutaneous Transfemoral Procedures: A Randomized Study

Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment

Clinical experience with the miltonia valve: short-term performance of new bi-leafet mechanical prosthesis in mitral valve replacement surgery 

Clinical Outcomes of Percutaneous Transcatheter Release of Stuck Mechanical Mitral Valve With Cerebral Embolic Protection

An investigation into the cellular-level adverse effects of tourniquet use on the infrapatellar fat pad in primary total knee arthroplasty: A prospective randomized study

A study to assess the clinical and functional outcome of sub-vastus approach for total knee arthroplasty

An investigation into the cellular-level adverse effects of
tourniquet use on the infrapatellar fat pad in primary total knee arthroplasty: A prospective randomized study

Erosion and Failure of the Tibial Post after Posterior-stabilized Total Knee Replacement: A Case Report

Rise of Revision Arthroplasties in Indian Subcontinent: An Inadvertent Future

Mid-term Outcomes of Patella Resurfacing During Total Knee Arthroplasty (TKA): Clinical, Functional, and Radiographic Insights

Safety and Functional Outcomes Following Total Hip Arthroplasty Using the Latitud™ Total Hip Replacement System in Patients With Hip Fracture

Total Hip Arthroplasty for Osteonecrosis of the Femoral Head: A Mid-term Follow-Up in Patients From Northern India

Safety and Efficacy of Latitud™ Hip Replacement in
Total Hip Arthroplasty: An Observational Study in
Kazakhstan 

Cemented bipolar hemiarthroplasty for unstable intertrochanteric fracture in elderly patients over 70 years: Boon or bane? 

Functional and clinical outcome with modified lateral approach total hip arthroplasty in stiff hips with ankylosing spondylitis

Ochronotic arthropathy of the hip with multiple joint involvement: a rare case report and literature review 

Partial replacement of pelvis with the hip joint in osteosarcoma treatment: A case report

Assessment of Patellofemoral Overstuffing on the Results of Total Knee Arthroplasty: An Observational Prospective Study

Robotic Total Knee Replacement: Our Experience with First 200 Knees 

Total Knee Replacement for Varus Deformity in Osteoarthritis of Knee with Multiple Hereditary Exostoses – A Rare Case Report

Stress Fracture of the Femoral Neck Following Total Knee Arthroplasty: A Case Series

Rise of Revision Arthroplasties in Indian Subcontinent: An Inadvertent Future

Minimized Soft Tissue Release in Robotic-Assisted Total Knee Arthroplasty: A Retrospective Review of 100 Cases

Assessment of average femoral component rotation for balancing functionally aligned total knee replacement in varus deformity: Robotic image guidance study

Analysis of robot-specific operative time and surgical team anxiety level and its effect on alignment during robot-assisted TKA

Comparison of Time Taken in Conventional versus Active
Robotic-Assisted Total Knee Arthroplasty

Intra-operative Safety of an Autonomous Robotic
System for Total Knee Replacement: A Review of 500 Cases in India

Efficacy of the Pre-operative Three-Dimensional (3D) CT
Scan Templating in Predicting Accurate Implant Size and Alignment in Robot-Assisted Total Knee Arthroplasty 

Mid-term Outcomes of Patella Resurfacing During Total Knee Arthroplasty (TKA): Clinical, Functional, and Radiographic Insights 

An Early Experience with a Novel Technique of Total Knee
Arthroplasty for Osteoarthritic Knee with Coexistent Traumatic Tibia Diaphysis Fracture

Evaluation of the safety and efficacy of the fully automated active robotic system in robotic-assisted total knee arthroplasty

Continuation of a Currently Available Primary Total Knee Arthroplasty System Design: 10-Year Follow-Up of Earlier Studies at 2- and 5-Years

Comparative mid-term evaluation of unilateral and bilateral total knee arthroplasty utilizing metal-backed
components: An assessment of functional and clinical outcomes (FREEDOM 400)

Comparison of Early Results Between Bone-Conserving
and Conventional High-Flexion Posterior-Stabilized Total Knee Arthroplasty

A comprehensive comparative study on mid-term clinical and functional outcomes in Indian patients following bilateral total knee arthroplasty: assessing the impact of body mass index on post-total knee arthroplasty results

Age wise comparative analysis of Patients undergoing total knee arthroplasty: a multicenter indigenous experience

A multi-centre retrospective study of the impact of body mass index on clinical and functional outcomes of total knee arthroplasty: An Indian prospective

Efficacy of the pre‑operative three‑dimensional (3D) CT scan templating in predicting accurate implant size and alignment in robot 

Early results of bone‑conserving high flexion posterior‑stabilized total knee system in Indian population

Education, engagement, and provision of empathy by trained counselor enhances the patient satisfaction after
total knee arthroplasty

Restoration of femoral condylar anatomy for achieving optimum functional expectations: continuation of an earlier study at 5-year minimum follow-up

Clinical evaluation of efficacy and performance of all-poly tibial Freedom® total knee system for treating osteoarthritis Patients: three-year follow up study

Restoration of femoral condylar anatomy for achieving optimum functional expectations: component
design and early results

Challenges in successful management of haemophilic knee arthropathy: our experience in a tertiary center

Can the subvastus approach for total knee arthroplasty help in achieving high flexion in highflex knees? Results of 242 knees at four years

Component size discrepancies and their influence on three-year outcomes in simultaneous bilateral total knee arthroplasty: A multicentral prospective study

One-stage total knee arthroplasty with long stemmed tibia for traumatic tibial diaphysis fracture with co-existing osteoarthritis of the knee

Comparison of conventional (CH) vs stapled haemorrhoidectomy (SH): three-yearss experience

Is mesh fixation necessary in laparoendoscopic techniques for M3 inguinal defects? An experimental study 

Long-Term Safety and Clinical Outcomes of Filaprop™ Mesh Variants in Elective Hernia Repair: A Multicenter Study

Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study

The Safety and Effectiveness of MERIZELLE Oxidized Regenerated Cellulose in Achieving Hemostasis Across Various Surgical Procedures-A Prospective, Multi-Center, Post-Marketing Surveillance Study

Clinical outcomes of stapled hemorrhoidopexy using a novel three-row stapler for grade III/IV hemorrhoids: A single-center experience with literature review

Our initial experience of three versus two rows circular stapler devices for stapled hemorrhoidopexy: a single institution review of 224 cases

Uni-center, patient-blinded, randomized, 12-month, parallel group, non-inferiority study to compare outcomes of 3-row vs 2-row circular staplers for colorectal anastomosis formation after low anterior resection for rectal cancer

Evaluation of safety and efficacy of Polyglactin 910 suture in surgical incision closure: clinical study protocol for a randomized controlled trial

Safety and Efficacy of triclosan-coated polyglactin 910 suture in prevention of surgical site infection in postpartum women: A randomized controlled trial

A comparative study of open vs laparoscopic repair in umbilical and para umbilical hernias

Safety and performance of a levonorgestrel-releasing intrauterine contraceptive device: one-year outcomes of Fiona-1 clinical registry

The safety and efficacy of clipless versus conventional laparoscopic cholecystectomy-our experience in an Indian rural center

A prospective, single-center study to evaluate the clinical performance of Meril ABFind in individuals vaccinated against Covid-19 

Comparison between haematological parameters by the Merilyzer Celquant 360™ automated haematology analyser and Sysmex XP-100 haematology analyser with them manual methods

A post-marketing surveillance study to evaluate performance of the EXIMO™ blood glucose monitoring system